Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/22/24 18:01 | 8/20/24 | CTMX | Health | Drug | Pharmaceutical Preparations | Landau Jeffrey B | CA | O | Chief Bu | 4 | S.d | -30 | 1.57 | 0 | -19 | 127 | D | |||||||||||||||
8/22/24 18:01 | 8/20/24 | CTMX | Health | Drug | Pharmaceutical Preparations | Belvin Marcia | CA | O | SVP,Chie | 4 | S.d | -43 | 1.70 | 0 | -25 | 176 | D | |||||||||||||||
8/22/24 18:00 | 8/20/24 | CTMX | Health | Drug | Pharmaceutical Preparations | Rowland Lloyd A | CA | O | GC | 4 | S.d | -29 | 1.52 | 0 | -19 | 131 | D | |||||||||||||||
8/22/24 17:59 | 8/20/24 | CTMX | Health | Drug | Pharmaceutical Preparations | Ogden Christopher | CA | O | CFO | 3 | S.d | -11 | 1.64 | 0 | -7 | 108 | D | |||||||||||||||
8/22/24 17:58 | 8/20/24 | CTMX | Health | Drug | Pharmaceutical Preparations | McCarthy Sean A. | CA | DO | CEO | 4 | S.d | -97 | 1.56 | 0 | -62 | 751 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |